Living Legends: Nick Morrell, Cambridge Heart and Lung Research Institute

Nick Morrell is Emeritus Professor of Medicine at the University of Cambridge, UK. Previously, Nick was the British Heart Foundation Professor of Cardiopulmonary Medicine at Cambridge and inaugural Director of The Cambridge Heart and Lung Research Institute. He has published over 300 papers in the fields of pulmonary arterial hypertension (PAH) and bone morphogenetic protein biology and was elected to the Fellowship of the Academy of Medical Sciences in 2011. He was awarded Doctor of Science (ScD) from Cambridge in 2018 and received a Lifetime Achievement Award for his research in PAH from the European Respiratory Society in 2019. As an active Fellow of the PVRI, he served as co-editor-in-chief  of Pulmonary Circulation for 10 years. In 2015 he founded Morphogen-IX, a university spin-out company to commercialise new treatments for PAH based on research from his laboratory in Cambridge. Morphogen-IX was acquired by Centessa Pharmaceuticals in 2021, and he then served as President of the BMP programme at Centessa. Nick co-founded a new start up biotech company in October 2023, Interact Bio Ltd, and currently serves as its Chief Scientific Officer. The company is focussed on developing transformative medicines for cardiovascular diseases with high unmet need, including pulmonary hypertension.